Diseases GBD, Injuries C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204–22.

Article  Google Scholar 

O’Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388(10046):761–75.

Article  PubMed  Google Scholar 

Lanas F, Seron P. Facing the stroke burden worldwide. Lancet Glob Health. 2021;9(3):e235–6.

Article  CAS  PubMed  Google Scholar 

Wang W, Jiang B, Sun H, Ru X, Sun D, Wang L, et al. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults. Circulation. 2017;135(8):759–71.

Article  PubMed  Google Scholar 

Wu S, Wu B, Liu M, Chen Z, Wang W, Anderson CS, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management. The Lancet Neurology. 2019;18(4):394–405.

Article  PubMed  Google Scholar 

James DE, Stockli J, Birnbaum MJ. The aetiology and molecular landscape of insulin resistance. Nat Rev Mol Cell Biol. 2021;22(11):751–71.

Article  CAS  PubMed  Google Scholar 

Li M, Chi X, Wang Y, Setrerrahmane S, Xie W, Xu H. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct Target Ther. 2022;7(1):216.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Niu ZJ, Cui Y, Wei T, Dou M, Zheng BX, Deng G, et al. The effect of insulin resistance in the association between obesity and hypertension incidence among Chinese middle-aged and older adults: data from China health and retirement longitudinal study (CHARLS). Front Public Health. 2024;12: 1320918.

Article  PubMed  PubMed Central  Google Scholar 

Liu L, Peng J, Wang N, Wu Z, Zhang Y, Cui H, et al. Comparison of seven surrogate insulin resistance indexes for prediction of incident coronary heart disease risk: a 10-year prospective cohort study. Front Endocrinol (Lausanne). 2024;15:1290226.

Article  PubMed  Google Scholar 

Reaven G. Insulin resistance, type 2 diabetes mellitus, and cardiovascular disease: the end of the beginning. Circulation. 2005;112(20):3030–2.

Article  PubMed  Google Scholar 

Bornfeldt KE, Tabas I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab. 2011;14(5):575–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tam CS, Xie W, Johnson WD, Cefalu WT, Redman LM, Ravussin E. Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care. 2012;35(7):1605–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.

Article  CAS  PubMed  Google Scholar 

Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, et al. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona diabetes complications study. Diabetes Care. 2002;25(7):1135–41.

Article  PubMed  Google Scholar 

Kumar NSS, Vanamala N, Vallampalli G, Thatikonda AK, Padala R. Insulin resistance as an inflammatory marker for ischemic stroke severity among non-diabetics: a prospective study. J Neurol Research. 2016;6(2–3):46–50.

Article  Google Scholar 

Chiang JK, Lai NS, Chang JK, Koo M. Predicting insulin resistance using the triglyceride-to-high-density lipoprotein cholesterol ratio in Taiwanese adults. Cardiovasc Diabetol. 2011;10: 93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304.

Article  PubMed  Google Scholar 

Mirr M, Skrypnik D, Bogdanski P, Owecki M. Newly proposed insulin resistance indexes called TyG-NC and TyG-NHtR show efficacy in diagnosing the metabolic syndrome. J Endocrinol Invest. 2021;44(12):2831–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, Wang R, Fu X, Song H. Non-insulin-based insulin resistance indexes in predicting severity for coronary artery disease. Diabetol Metab Syndr. 2022;14(1):191.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D, Viveros-Ruiz T, Cruz-Bautista I, Romo-Romo A, et al. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol. 2018;178(5):533–44.

Article  CAS  PubMed  Google Scholar 

Cai XT, Zhu Q, Liu SS, Wang MR, Wu T, Hong J, et al. Associations between the metabolic score for insulin resistance index and the risk of type 2 diabetes mellitus among non-obese adults: insights from a population-based cohort study. Int J Gen Med. 2021;14:7729–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu Z, Cui H, Zhang Y, Liu L, Zhang W, Xiong W, et al. The impact of the metabolic score for insulin resistance on cardiovascular disease: a 10-year follow-up cohort study. J Endocrinol Invest. 2023;46(3):523–33.

Article  CAS  PubMed  Google Scholar 

Qian T, Sheng X, Shen P, Fang Y, Deng Y, Zou G. Mets-IR as a predictor of cardiovascular events in the middle-aged and elderly population and mediator role of blood lipids. Front Endocrinol (Lausanne). 2023;14:1224967.

Article  PubMed  Google Scholar 

Cai X, Hu J, Zhu Q, Wang M, Liu S, Dang Y, et al. Relationship of the metabolic score for insulin resistance and the risk of stroke in patients with hypertension: a cohort study. Front Endocrinol (Lausanne). 2022;13:1049211.

Article  PubMed  Google Scholar 

Bello-Chavolla OY, Antonio-Villa NE, Vargas-Vazquez A, Martagon AJ, Mehta R, Arellano-Campos O, et al. Prediction of incident hypertension and arterial stiffness using the non-insulin-based metabolic score for insulin resistance (METS-IR) index. J Clin Hypertens (Greenwich). 2019;21(8):1063–70.

Article  CAS  PubMed  Google Scholar 

Paublini H, López González AA, Busquets-Cortés C, Tomas-Gil P, Riutord-Sbert P, Ramírez-Manent JI. Relationship between atherogenic dyslipidaemia and lipid triad and scales that assess insulin resistance. Nutrients. 2023;15(9):2105.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu G. Association between the metabolic score for insulin resistance (METS-IR) and arterial stiffness among health check-up population in Japan: a retrospective cross-sectional study. Front Endocrinol (Lausanne). 2023;14:1308719.

Article  PubMed  Google Scholar 

Wu Z, Cui H, Li W, Zhang Y, Liu L, Liu Z, et al. Comparison of three non-insulin-based insulin resistance indexes in predicting the presence and severity of coronary artery disease. Front Cardiovasc Med. 2022;9: 918359.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pan L, Zou H, Meng X, Li D, Li W, Chen X, et al. Predictive values of metabolic score for insulin resistance on risk of major adverse cardiovascular events and comparison with other insulin resistance indices among Chinese with and without diabetes mellitus: results from the 4C cohort study. J Diabetes Investig. 2023;14(8):961–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Golubnitschaja O, Potuznik P, Polivka J Jr, Pesta M, Kaverina O, Pieper CC, et al. Ischemic stroke of unclear aetiology: a case-by-case analysis and call for a multi-professional predictive, preventive and personalised approach. EPMA J. 2022;13(4):535–45.

Article  PubMed  PubMed Central